Inhibition of corneal neovascularization by recombinant adenovirus-mediated sFlk-1 expression
- 1 August 2007
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 361 (4) , 946-952
- https://doi.org/10.1016/j.bbrc.2007.07.114
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Inhibition of Corneal Neovascularization by Recombinant Adenovirus Mediated Antisense VEGF RNAExperimental Eye Research, 2002
- Corneal neovascularizationCurrent Opinion in Opthalmology, 2001
- CD18 and ICAM-1-Dependent Corneal Neovascularization and Inflammation after Limbal InjuryThe American Journal of Pathology, 2000
- Ocular NeovascularizationSurvey of Ophthalmology, 1998
- Mechanisms of angiogenesisNature, 1997
- Endothelial receptor tyrosine kinases involved in angiogenesis.The Journal of cell biology, 1995
- Fetal liver kinase 1 is a receptor for vascular endothelial growth factor and is selectively expressed in vascular endothelium.Proceedings of the National Academy of Sciences, 1993
- High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesisCell, 1993
- Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factorBiochemical and Biophysical Research Communications, 1992
- The fms -Like Tyrosine Kinase, a Receptor for Vascular Endothelial Growth FactorScience, 1992